Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Treatment of Social Phobia Over the Internet [NA]
A clinical trial testing internet-delivered treatment for social anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder [NA]
A completed trial from Umeå University evaluating Attention Bias Modification Training for Social Anxiety Disorder (social phobia).
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT [NA]
A completed clinical trial at Umeå University evaluating the combination of cognitive bias modification and internet-delivered cognitive-beh…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Treatment of Social Phobia With Cognitive Bias Modification [NA]
A clinical trial evaluating cognitive bias modification for social anxiety disorder (social phobia) has completed. The sponsor is Umeå Unive…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder [Phase 2]
A Phase 2 clinical trial of GW679769 sponsored by GlaxoSmithKline for Social Anxiety Disorder and related anxiety disorders has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Interpretive Biases in Children With Social Anxiety [NA]
A clinical trial led by the University of Wisconsin–Milwaukee investigating interpretive biases in children with social anxiety has been ter…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Brief Behavioral Treatment for Anxiety in Young Children [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1 and Phase 2 evaluations of Brief Behavioral Treatment for Anxiety in young chil…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
A clinical trial update presenting an individual patient data meta-analysis assessing baseline severity and antidepressant efficacy across s…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Combination Therapy In Patients With Social Anxiety Disorder [Phase 2]
Phase 2 clinical trial of a combination therapy for social anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients [Phase 2]
Phase 2 PET/public speaking trial using a two-drug combination in social anxiety disorder has completed; results are not detailed in the pro…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder [Phase 4]
This document reports a Phase 4 clinical trial comparing vortioxetine to placebo in adults with major depressive disorder and comorbid socia…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Gaze Contingent Feedback in Social Anxiety Disorder [NA]
A clinical trial evaluating gaze-contingent feedback as an intervention for social anxiety disorder has completed.
-
FDA approval · 2016-06-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride (Vertical Pharmaceuticals, LLC). This action expands the sponsor's NDA…
-
FDA approval · 2016-06-10FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original ANDA for paroxetine (paroxetine hydrochloride), establishing a generic version of the antidepr…
-
CLINICAL_TRIALS research · 2016-05-06Clinical Trial Update: Internet-delivered Transdiagnostic Intervention for Anxiety and Depression [NA]
This clinical trial update describes an internet-delivered transdiagnostic intervention for anxiety and depression, covering multiple disord…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Venlafaxine PK Following Bariatric Surgery [Phase 4]
Phase 4 study evaluating how bariatric surgery affects the pharmacokinetics of venlafaxine has completed, assessing changes in drug exposure…
-
FDA approval · 2016-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling the commercialization of a gene…
-
FDA approval · 2016-02-29FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: CBT vs. ABM vs. for Social Anxiety [NA]
A completed clinical trial from Hebrew University of Jerusalem comparing cognitive behavioral therapy and attention bias modification for so…
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: CBT for Social Anxiety Disorder Delivered by School Counselors [Phase 2]
A Phase 2 clinical trial evaluating cognitive-behavioral therapy delivered by school counselors for social anxiety disorder has completed.
-
FDA approval · 2016-01-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Treatment of Social Phobia and Panic Disorder in Adults [Phase 3]
Phase 3 clinical trial update on treatments for social anxiety disorder and panic disorder in adults. The study status is completed.
-
FDA approval · 2016-01-20FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approves a supplemental application for venlafaxine hydrochloride submitted by Zydus Pharmaceuticals USA Inc., resulting in regulatory a…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: Sleep, Mood, and Behavior Study [NA]
A completed clinical trial update from the University of Pittsburgh reports on sleep, mood, and behavior in children with anxiety disorders,…
-
FDA approval · 2015-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Lupin Pharmaceuticals, Inc.), a generic product under an ANDA.